17772-102Level 3
Trokendi XR (topiramate)
**Product type:** Human Prescription Drug
**Active ingredient:** TOPIRAMATE
**Strength:** 50 mg/1
**Dosage form:** Capsule, Extended Release
**Route:** Oral
**Labeler:** Supernus Pharmaceuticals, Inc.
**Marketing category:** NDA (NDA201635)
**Pharmacologic class:** Cytochrome P450 2C19 Inhibitors [MoA], Cytochrome P450 3A4 Inducers [MoA], Decreased Central Nervous System Disorganized Electrical Activity [PE]
GET
/api/v1/systems/ndc_fda/nodes/17772-102Hierarchy Explorer
Loading...
Cross-system equivalences0
No cross-system equivalences mapped for this node.